Fig. 4.
Fig. 4. Screening of anti–HSV antibody–producing cells. / Supernatants from the first round (A) and the second round (B) of limiting dilution using EBV-transformed LCLs established from the patient were collected and screened by a Herpes Simplex IgG detection kit as described in “Materials and methods.” OD at 450 nm was measured in both experiments. N, negative control; P, positive control. (C) Sequence analysis of the positive clone (clone 67-2) after the second round of limiting dilution, indicating that the clone was of host origin. An asterisk indicates the position of the paternal mutation.

Screening of anti–HSV antibody–producing cells.

Supernatants from the first round (A) and the second round (B) of limiting dilution using EBV-transformed LCLs established from the patient were collected and screened by a Herpes Simplex IgG detection kit as described in “Materials and methods.” OD at 450 nm was measured in both experiments. N, negative control; P, positive control. (C) Sequence analysis of the positive clone (clone 67-2) after the second round of limiting dilution, indicating that the clone was of host origin. An asterisk indicates the position of the paternal mutation.

Close Modal

or Create an Account

Close Modal
Close Modal